Source: Annual Congress 2013 –Airway calibre, airway challenge and assessment of oxygenation
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Bryce, K. Oates, G. Chivers, H. Parfrey (Cambridge, United Kingdom). Determining why patients with idiopathic pulmonary fibrosis (IPF) have difficulty performing gas transfer. Eur Respir J 2013; 42: Suppl. 57, 1291

Member's Comments

No comment yet.

Related content which might interest you: Pattern of diffusion disturbance in patients with interstitial lung diseases (ILDs) Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS) Source: International Congress 2014 – Innovative technology and techniques in respiratory function Year: 2014 Changes in pulmonary gas exchange in histiocytosis X patients depending on the type of ventilation disorders Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Optimal use of gas transfer values in detecting pulmonary vascular involvement in sarcoidosis Source: International Congress 2015 – Sarcoidosis: clinical Year: 2015 Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012 The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Novel lung function tests in patients with interstitial lung disease (ILD) Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016 A trial of the measurement of dynamic lung compliance by the new method using photoplethysmography in patients with COPD and pulmonary fibrosis Source: International Congress 2016 – The future of lung function is beginning now Year: 2016 Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Cardiac function in idiopathic pulmonary arterial hypertension patients with a severely reduced diffusion capacity Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 What (and how) do we attain by performing surgical lung biopsy for interstitial lung disease? Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment Source: International Congress 2016 – IPF treatment I Year: 2016 Analyses of the relationship between ΔFVC, extent of fibrosis and extent of emphysema in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2016 – IPF clinical Year: 2016 The decline in lung function is related to both emphysema and fibrosis extent in patients with idiopathic pulmonary fibrosis (IPF)/ combined pulmonary fibrosis and emphysema (CPFE) Source: International Congress 2014 – ILDs 1 Year: 2014 Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Comparison of physiological impairment in ILD patients with and without diagnostic IPF features Source: International Congress 2014 – ILDs 4 Year: 2014 Effect of baseline FVC on lung function decline with nintedanib in patients with IPF Source: International Congress 2015 – Treatment of IPF Year: 2015